4.77BMarket Cap-34219P/E (TTM)
97.285High94.140Low381.95KVolume96.680Open96.890Pre Close36.44MTurnover0.79%Turnover RatioLossP/E (Static)50.19MShares102.33052wk High10.34P/B4.59BFloat Cap45.38052wk Low--Dividend TTM48.27MShs Float102.330Historical High--Div YieldTTM3.25%Amplitude14.250Historical Low95.398Avg Price1Lot Size
Glaukos Stock Forum
PDUFA Update…
$Arcutis Biotherapeutics(ARQT.US)$ : Approved 12/15
• ZORYVE® (Roflumilast foam 0.3%)
⇒ topical foam
⇒ PDUFA: 12/16/23
⇒ NDA
⇒ Seborrheic dermatitis
$Merck & Co(MRK.US)$ : Approved 12/15
• KEYTRUDA (pembrolizumab) + Padcev (enfortumab vedotin-ejfv)
⇒ IV injection
⇒ PDUFA: 05/09/24
⇒ sBLA
⇒ Urothelial cancer
$Glaukos(GKOS.US)$ : Approved 12/14
• iDose® TR (travoprost)
⇒ intracameral implant
⇒ PDUFA: 12/22/23
⇒ NDA
⇒ Glaucoma
$Merck & Co(MRK.US)$ : Approved ...
PDUFA Events for December 2023
Join us to connect and share, and to get info fast!
$CRISPR Therapeutics(CRSP.US)$$Vertex Pharmaceuticals(VRTX.US)$$OptiNose(OPTN.US)$$Arcutis Biotherapeutics(ARQT.US)$$Calliditas Therapeutics(CALT.US)$$bluebird bio(BLUE.US)$$Glaukos(GKOS.US)$$Ionis Pharmaceuticals(IONS.US)$$Amgen(AMGN.US)$$Merck & Co(MRK.US)$
Let’s see if this bounces
im seeing some decent chart upside here
thoughts?
Health Care Sector Update for 08/24/2022: SPRC,GKOS,BCDA
$SciSparc(SPRC.US)$ rallied Wednesday, climbing over 20%, after the Israeli pharmaceuticals company said the psychedelic-based MEAI drug candidate developed with Canadian collaborator Clearmind Medicine produced a significant decrease in coccaine craving in rats compared to those in a non-treated control group during pre-clinical testing.
$Glaukos(GKOS.US)$ gained 6% after We...
ColumnsToday's pre-market stock movers: PTON, PEP, NVAX, GPS and more
• $Canoo(GOEV.US)$ +71.3% (receives purchase order of 4500 Canoo Electric Delivery Vehicles from Walmart)
• $Aldeyra Therapeutics(ALDX.US)$ +14.1% (achieved primary endpoints in dry eye disease chamber crossover clinical trial)
• $Westport Fuel(WPRT.US)$ +10.9% (awarded 38 mln program)
• $Greenwich LifeSciences(GLSI.US)$ +5.9% (FDA has removed the clinical hold permitting the Flamingo-01 Phase III clinical trial to proceed...
No comment yet